Sulfacetamide Sodium

Ophthalmia, Sympathetic, Collagen Diseases, Uveitis + 12 more
Treatment
24 FDA approvals
20 Active Studies for Sulfacetamide Sodium

What is Sulfacetamide Sodium

Prednisolone phosphateThe Generic name of this drug
Treatment SummaryAn antibiotic drug used to treat skin infections when applied to the skin, and urinary tract infections when taken orally.
Pediapredis the brand name
image of different drug pills on a surface
Sulfacetamide Sodium Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Pediapred
Prednisolone phosphate
1986
71

Approved as Treatment by the FDA

Prednisolone phosphate, also called Pediapred, is approved by the FDA for 24 uses such as Conjunctivitis and Uveitis .
Conjunctivitis
Uveitis
Endocrine System Diseases
Disease
Endocrine Disorders
Ocular Inflammation
Giant Cell Arteritis
Uveitis
Skin Diseases
Hypersensitivity
Multiple Sclerosis
Swollen feet or ankles
Neoplastic Disease
Allergic Conditions
Collagen Diseases
Temporal Arteritis
Respiratory Diseases
Ophthalmia, Sympathetic
Multiple sclerosis exacerbation
Dermatological Disease
Gastroenteritis
Uveitis
Edema
Gastrointestinal Diseases

Effectiveness

How Sulfacetamide Sodium Affects PatientsSulfacetamide is a type of antibiotic that works by preventing bacteria from multiplying. It is effective against most types of bacteria, though some may be resistant. The drug can be taken orally, but it is difficult to administer it through other means because it can be irritating to the tissues. Sulfacetamide is present in many different parts of the body, including the pleural, peritoneal, synovial, and ocular fluids. It used to be used to treat meningitis, but its effects are hampered by pus.
How Sulfacetamide Sodium works in the bodySulfacetamide works by blocking the production of folic acid in bacteria. It does this by stopping a key reaction that requires para-aminobenzoic acid (PABA) to take place.

When to interrupt dosage

The prescribed dosage of Sulfacetamide Sodium is contingent upon the diagnosed disorder, including superficial ocular infections, Conjunctivitis and Trachoma. The quantity of dosage may differ, depending on the technique of administration (e.g. Solution - Ophthalmic or Aerosol, foam) featured in the table below.
Condition
Dosage
Administration
Multiple Sclerosis
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Collagen Diseases
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Respiratory Diseases
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Skin Diseases
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Swollen feet or ankles
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Disease
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Endocrine System Diseases
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Uveitis
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Urinary Tract Infection (UTI)
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Conjunctivitis
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Giant Cell Arteritis
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Gastroenteritis
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Hypersensitivity
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Ophthalmia, Sympathetic
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Neoplastic Disease
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral

Warnings

Sulfacetamide Sodium Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Prednisolone Phosphate may interact with Pulse Frequency
There are 20 known major drug interactions with Sulfacetamide Sodium.
Common Sulfacetamide Sodium Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The serum concentration of Abemaciclib can be decreased when it is combined with Prednisolone phosphate.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Prednisolone phosphate.
Aldesleukin
Major
The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisolone phosphate.
Alectinib
Major
The metabolism of Alectinib can be increased when combined with Prednisolone phosphate.
Alpelisib
Major
The metabolism of Alpelisib can be increased when combined with Prednisolone phosphate.
Sulfacetamide Sodium Toxicity & Overdose RiskThe lowest toxic dose of this drug for mice is 16500mg/kg. Possible side effects include redness and swelling of the skin, nausea, vomiting, headaches, dizziness, and fatigue. Larger doses may lead to loss of consciousness.
image of a doctor in a lab doing drug, clinical research

Sulfacetamide Sodium Novel Uses: Which Conditions Have a Clinical Trial Featuring Sulfacetamide Sodium?

29 active clinical trials are assessing the potential of Sulfacetamide Sodium to alleviate Trachoma, Acne and Superficial Ocular Infections.
Condition
Clinical Trials
Trial Phases
Uveitis
3 Actively Recruiting
Not Applicable, Phase 1, Phase 3
Giant Cell Arteritis
0 Actively Recruiting
Conjunctivitis
0 Actively Recruiting
Disease
0 Actively Recruiting
Urinary Tract Infection (UTI)
9 Actively Recruiting
Phase 1, Phase 3, Phase 4, Not Applicable
Swollen feet or ankles
6 Actively Recruiting
Phase 2, Not Applicable
Endocrine System Diseases
0 Actively Recruiting
Multiple Sclerosis
0 Actively Recruiting
Skin Diseases
1 Actively Recruiting
Phase 2
Gastroenteritis
5 Actively Recruiting
Not Applicable
Respiratory Diseases
5 Actively Recruiting
Not Applicable
Collagen Diseases
11 Actively Recruiting
Not Applicable, Phase 4, Phase 1, Phase 3, Phase 2
Ophthalmia, Sympathetic
0 Actively Recruiting
Hypersensitivity
0 Actively Recruiting
Neoplastic Disease
1 Actively Recruiting
Phase 1

Patient Q&A Section about sulfacetamide sodium

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is sulfacetamide sodium solution used for?

"Ophthalmic sulfacetamide is an antibiotic that prevents the growth of bacteria that cause certain eye infections. It is used to treat eye infections and to prevent them from occurring after injuries."

Answered by AI

Is sulfacetamide sodium used for pink eye?

"This drug is used to treat bacterial eye infections. It is in a class of drugs called sulfa antibiotics."

Answered by AI

How long does sulfacetamide take to work?

"How long does it take for Avar (sulfacetamide / sulfur) to start working? It is important to use this medication as prescribed by your healthcare provider. It can take up to 12 weeks to see results. The severity of the condition being treated and the individual may affect how long it takes to see results."

Answered by AI

How long can you use sodium sulfacetamide?

"Sodium sulfacetamide cream and gel should be applied to affected areas twice daily for 8 to 10 days. Between applications, the interval may be lengthened as conditions improve. Using the cream or gel 1 to 2 times a week or every other week may help prevent reoccurrences."

Answered by AI

Clinical Trials for Sulfacetamide Sodium

Have you considered Sulfacetamide Sodium clinical trials? We made a collection of clinical trials featuring Sulfacetamide Sodium, we think they might fit your search criteria.
Have you considered Sulfacetamide Sodium clinical trials? We made a collection of clinical trials featuring Sulfacetamide Sodium, we think they might fit your search criteria.
Have you considered Sulfacetamide Sodium clinical trials? We made a collection of clinical trials featuring Sulfacetamide Sodium, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top